| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xie,Hong-Liang | Chairman | 9.74% | |
| Xu,Ming-Qi | Vice Chairman | 0.31% | |
| Yang,Zheng-Li | Independent Director | 0.00% | |
| Fang,Song-Ren | Independent Director | 0.00% | |
| Xin,Shui-Quan | Independent Director | 0.00% | |
| Lin,Jun-Ji | Independent Director | 0.00% | |
| Hu,Han-Liang | Director | 0.00% | |
| Xiao,Chong-He | Director | 0.30% | |
| Xie,Wei-Ling | Director | 1.98% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 2,812,388 | 9,688,280 | 6,911,981 |
| Operating cost | 1,920,379 | 6,787,607 | 4,705,858 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 892,009 | 2,900,673 | 2,206,123 |
| Unrealized profit (loss) on sales of goods | - | -5,154 | 4,791 |
| Realized profit (loss) on sales of goods | 1,368 | - | - |
| Operating gross profit (loss), net | 893,377 | 2,905,827 | 2,201,332 |
| Operating expenses | 544,598 | 1,790,278 | 1,483,610 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 348,779 | 1,115,549 | 717,722 |
| Non-operating income and expenses | 17,726 | 161,155 | 142,622 |
| Net profit (loss) before tax | 366,505 | 1,276,704 | 860,344 |
| Income tax expense (benefits) | 96,962 | 349,721 | 210,042 |
| Net profit (loss) of ongoing business for the current period | 269,543 | 926,983 | 650,302 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 269,543 | 926,983 | 650,302 |
| Other comprehensive profit (loss), net | 50,641 | 135,205 | 58,294 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 320,184 | 1,062,188 | 708,596 |
| Net profit (loss) attributable to owners of parent company | 257,326 | 926,983 | 650,302 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 12,217 | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 305,389 | 1,062,188 | 708,596 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 14,795 | - | - |
| Basic earnings per share (yuan) | 3 | 11 | 8 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -20,007 | 1,725,631 | 1,004,121 |
| Net cash inflows (outflows) from investing activities | -378,748 | -761,101 | 25,611 |
| Net cash inflow (outflow) from financing activities | -609,169 | 1,282,185 | -427,779 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 32,276 | 107,225 | -22,927 |
| Increase (decrease) in cash and cash equivalents in the current period | -975,648 | 2,353,940 | 579,026 |
| Beginning balance of cash and cash equivalents | 7,014,917 | 4,660,977 | 4,081,951 |
| Ending balance of cash and cash equivalents | 6,039,269 | 7,014,917 | 4,660,977 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 19,671,925 | 20,094,282 | 16,406,915 |
| Non-current asset | 4,159,858 | 3,389,459 | 2,515,932 |
| Total asset | 23,831,783 | 23,483,741 | 18,922,847 |
| Current liability | 17,088,981 | 16,987,268 | 14,727,105 |
| Non-current liability | 1,564,029 | 1,534,468 | 206,489 |
| Total liability | 18,653,010 | 18,521,736 | 14,933,594 |
| share capital | 803,280 | 803,280 | 803,280 |
| Equity - secruity token | - | - | - |
| capital reserve | 917,777 | 917,777 | 685,901 |
| retained earning | 2,975,080 | 3,080,882 | 2,474,871 |
| Other equity | 208,129 | 160,066 | 25,201 |
| Treasury stock | - | 0 | 0 |
| Total equity attributable to owners of parent company | 4,904,266 | 4,962,005 | 3,989,253 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 274,507 | - | 0 |
| Total Equity | 5,178,773 | 4,962,005 | 3,989,253 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 61 | 61 | 49 |
Others
2009, 2016
Provisional injunction
2015
Preservation of evidence
2015
Exclude patent infringement, etc.
2016, 2017, 2018
Others
2015, 2016, 2017
Payment order
2010, 2013
Payment, etc.
2016
Return deposit
2010, 2016
Pay remuneration
2009
New patent filing
2019, 2020, 2021, 2022
Pay for the goods
2008, 2011, 2013, 2016
Motion of objection
2011
Invalidating Judgment
2007
Invention patent filing
2016, 2017, 2018, 2019, 2021
Delivery of court audio CDs
2016
Invalidating Judgment (Note)
2013, 2014
Pay the buying and selling price
2009
Exclude patent infringement, etc.
2018
Petition filed for public summons
2012, 2014
Petition for confidentiality preservation order
2016, 2017
Infringement of patent rights related to property rights disputes
2014, 2015, 2016, 2017, 2018
Infringement of patent rights related to property rights disputes, etc.
2012, 2013, 2014, 2015, 2016
